Neuroleptic malignant syndrome and carbamazepine?
van Amelsvoort
T
T
D002220:Carbamazepine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D012307:Risk Factors
D002220:Carbamazepine